|
|
Hokkaido University Collection of Scholarly and Academic Papers >
Hokkaido University Hospital >
Peer-reviewed Journal Articles, etc >
The prognosis of endometrial cancers stratified with conventional risk factors and modified molecular classification
| Title: | The prognosis of endometrial cancers stratified with conventional risk factors and modified molecular classification |
| Authors: | Yamazaki, Hiroyuki Browse this author | | Asano, Hiroshi Browse this author | | Hatanaka, Kanako C. Browse this author | | Matsuoka, Ryosuke Browse this author | | Konno, Yosuke Browse this author →KAKEN DB | | Matsuno, Yoshihiro Browse this author | | Hatanaka, Yutaka Browse this author →KAKEN DB | | Watari, Hidemichi Browse this author →KAKEN DB |
| Keywords: | adjuvant chemotherapy | | endometrial cancer | | lymphadenectomy | | molecular classification | | survival |
| Issue Date: | Sep-2022 |
| Publisher: | John Wiley & Sons |
| Journal Title: | Cancer science |
| Volume: | 113 |
| Issue: | 9 |
| Start Page: | 3134 |
| End Page: | 3147 |
| Publisher DOI: | 10.1111/cas.15460 |
| Abstract: | This study aimed to validate the Proactive Molecular Risk Classifier for Endometrial Cancer, a modified version of The Cancer Genome Atlas, using data from 184 patients with endometrial cancer (median age: 57.5 years; median follow-up period: 109 months) who had undergone radical surgery (including systemic lymphadenectomy) and subsequent adjuvant chemotherapy (patients with intermediate or high recurrence risk) from 2003 to 2015. Tissue microarrays were prepared from surgical specimens and classified using the conventional clinical risk classifier. Immunohistochemistry was used to detect mismatch repair proteins, L1 cell adhesion molecule, and p53. Direct sequencing was used to identify hotspot mutations in the polymerase-epsilon gene. Forty-five patients were identified as having high L1 cell adhesion molecule expression, 41 as low risk, 34 as mismatch repair-deficient, 13 as polymerase-epsilon gene-mutated, five as having abnormal p53, and 46 as other. Patients were stratified into significantly different prognostic groups (p < 0.0001): favorable (low risk and polymerase-epsilon gene-mutated), intermediate (mismatch repair-deficient and other), and unfavorable (high L1 cell adhesion molecule expression and abnormal p53) with 5-year disease-specific survival rates of 100%, 93.8%, and 75.1%, respectively (Kaplan-Meier method). The combination of conventional recurrent risk classification, sequencing for polymerase-epsilon gene mutations and immunohistochemistry for L1 cell adhesion molecule, p53, and mismatch repair proteins can be used to determine the prognoses of patients with endometrial cancer. |
| Type: | article |
| URI: | http://hdl.handle.net/2115/86787 |
| Appears in Collections: | 北海道大学病院 (Hokkaido University Hospital) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|
|
